{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The collection of abstracts provided spans a wide array of studies addressing chromatin remodeling, oncogenic signaling, epigenetic regulation, and therapeutic vulnerabilities in ovarian and other cancers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " Many of these studies detail the tumor‐suppressive roles of SWI/SNF subunits (for instance, ARID1A, SMARCA4, ARID1B) and pinpoint vulnerabilities in signaling cascades (including EZH2 dependency, PI3K/AKT dysregulation, and altered mitotic regulation) that contribute directly to ovarian tumor initiation, progression, metastasis, and chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": " Equally, several reports explore how epigenetic mechanisms and aberrant gene regulation underlie both metastatic behavior and treatment resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Despite this extensive coverage of transcriptional, epigenetic, and signaling regulators in cancer, none of the abstracts directly address or characterize ESS2. Although ESS2 (sometimes referenced in the literature as a putative splicing or transcriptional regulatory factor) may be implicated in the modulation of gene expression programs similar to other chromatin–associated factors, the current literature provided does not include experimental or mechanistic data regarding ESS2 function. Studies in related areas suggest that precise regulation of chromatin structure and RNA processing is critical in tumorigenesis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", but no direct link to ESS2 is apparent. \n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, while the abstracts collectively underscore the significance of chromatin remodelers, transcription factors, and epigenetic modifiers in driving the oncogenic process and therapeutic responses in ovarian and other cancers"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", none of these works specifically investigate or detail the biological role of ESS2. This gap highlights that the function of ESS2 in cancer biology remains undetermined within this set of literature and warrants further focused investigation.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ARID1A mutations in endometriosis-associated ovarian carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa1008433"}], "href": "https://doi.org/10.1056/NEJMoa1008433"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20942669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20942669"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yilong Zou, Michael J Palte, Amy A Deik, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-09277-9"}], "href": "https://doi.org/10.1038/s41467-019-09277-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30962421"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30962421"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kimberly H Kim, Woojin Kim, Thomas P Howard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3968"}], "href": "https://doi.org/10.1038/nm.3968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26552009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26552009"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Katherine C Helming, Xiaofeng Wang, Boris G Wilson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ARID1B is a specific vulnerability in ARID1A-mutant cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3480"}], "href": "https://doi.org/10.1038/nm.3480"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24562383"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24562383"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "E M Alexandrova, A R Yallowitz, D Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature14430"}], "href": "https://doi.org/10.1038/nature14430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26009011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26009011"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-1178"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-1178"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19654294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19654294"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Anthony N Karnezis, Yemin Wang, Pilar Ramos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pathol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/path.4633"}], "href": "https://doi.org/10.1002/path.4633"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26356327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26356327"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Therese Phillips, Pauline Simmons, Hector D Inzunza, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000256"}], "href": "https://doi.org/10.1097/PAI.0000000000000256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26317305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26317305"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Akira Yokoi, Yusuke Yoshioka, Yusuke Yamamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms14470"}], "href": "https://doi.org/10.1038/ncomms14470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28262727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28262727"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jason Karch, Jennifer Q Kwong, Adam R Burr, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.00772"}], "href": "https://doi.org/10.7554/eLife.00772"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23991283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23991283"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Andrea D Basso, Asra Mirza, Gongjie Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M503763200"}], "href": "https://doi.org/10.1074/jbc.M503763200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16006564"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16006564"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Naomi Nakayama, Kentaro Nakayama, Yeasmin Shamima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cncr.24987"}], "href": "https://doi.org/10.1002/cncr.24987"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20336784"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20336784"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jenifer L Marks, Yixuan Gong, Dhananjay Chitale, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-0099"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-0099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18632602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18632602"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Melissa S Derycke, Stefan E Pambuccian, C Blake Gilks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Clin Pathol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1309/AJCPGXK0FR4MHIHB"}], "href": "https://doi.org/10.1309/AJCPGXK0FR4MHIHB"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20959669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20959669"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "John D Kanady, Michael T Dellinger, Stephanie J Munger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ydbio.2011.04.004"}], "href": "https://doi.org/10.1016/j.ydbio.2011.04.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21515254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21515254"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Celia S L Mak, Mingo M H Yung, Lynn M N Hui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0582-2"}], "href": "https://doi.org/10.1186/s12943-017-0582-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28095864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28095864"}]}]}]}